Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-000565
Filing Date
2023-03-31
Accepted
2023-03-31 16:31:37
Documents
65
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ckpt-20221231x10k.htm   iXBRL 10-K 1684979
2 EX-4.6 ckpt-20221231xex4d6.htm EX-4.6 60534
3 EX-23.1 ckpt-20221231xex23d1.htm EX-23.1 3315
4 EX-23.2 ckpt-20221231xex23d2.htm EX-23.2 2420
5 EX-31.1 ckpt-20221231xex31d1.htm EX-31.1 10190
6 EX-31.2 ckpt-20221231xex31d2.htm EX-31.2 10166
7 EX-32.1 ckpt-20221231xex32d1.htm EX-32.1 5250
8 EX-32.2 ckpt-20221231xex32d2.htm EX-32.2 5202
9 GRAPHIC ckpt-20221231x10k002.jpg GRAPHIC 2475
10 GRAPHIC ckpt-20221231xex23d1001.jpg GRAPHIC 3743
  Complete submission text file 0001410578-23-000565.txt   6728222

Data Files

Seq Description Document Type Size
11 EX-101.SCH ckpt-20221231.xsd EX-101.SCH 53532
12 EX-101.CAL ckpt-20221231_cal.xml EX-101.CAL 33772
13 EX-101.DEF ckpt-20221231_def.xml EX-101.DEF 243956
14 EX-101.LAB ckpt-20221231_lab.xml EX-101.LAB 455581
15 EX-101.PRE ckpt-20221231_pre.xml EX-101.PRE 354990
59 EXTRACTED XBRL INSTANCE DOCUMENT ckpt-20221231x10k_htm.xml XML 981985
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

EIN.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38128 | Film No.: 23788347
SIC: 2834 Pharmaceutical Preparations